The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Andre Uddin - Research Capital Corporation - Analyst
: Hi Brent and, Katie, I just, nice quarter. As you get more familiar with your business, can you discuss if you're starting to see a seasonal pattern? Like
if you look at 11, it used to be a weaker quarter and now it was stronger than we expected. Maybe you could just talk a little bit about that. Thanks.
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
FEBRUARY 21, 2025 / 1:30PM, COV.V - Q1 2025 Covalon Technologies Ltd Earnings Call
Question: Andre Uddin - Research Capital Corporation - Analyst
: Okay, thanks for it and just.
Could you also just provide a little bit more clarity in terms of the collagen channel inventory in in terms of what's happening there and.
A little bit more than what was in the release.
Question: Andre Uddin - Research Capital Corporation - Analyst
: Okay, that's great. It's just one last one I had just you added 21 new hospitals this quarter, which is, quite significant. Do you expect that trend to
continue for the rest of the year and how do you see hospital-based acquisitions going?
Question: Andre Uddin - Research Capital Corporation - Analyst
: Okay, that's great. Thanks. Thanks.
Question: Dave Kepler - Spirit Aerosystens - Analyst
: Morning, Brent. Just wondering if you can give an update on the coding business.
Question: Dave Kepler - Spirit Aerosystens - Analyst
: And last question, how do you, where do you see the company going? Are you going to be a high growth company or are you just going to be a
steady growth company, maybe, eventually buying back shares or even potentially paying a dividend?
| 
